124 related articles for article (PubMed ID: 1982201)
1. The in vivo and in vitro activity of AHR-13268D, a new antiallergic/antihistaminic agent.
Nolan JC; Foxwell MH; Whitman LL; Johnson DN; Yanni JM; Greene SV
Agents Actions; 1990 Nov; 31(3-4):210-8. PubMed ID: 1982201
[TBL] [Abstract][Full Text] [Related]
2. AHR-14310C: a potent, long-acting, nonsedating H1-antihistamine that prevents antigen-induced mucus formation in sensitive rats.
Nolan JC; Foxwell MH; Whitman LL; Yanni JM; Walsh DA; Kilpatrick BF; Johnson DN; Proakis AG
J Pharmacol Exp Ther; 1990 Jun; 253(3):1177-83. PubMed ID: 1972750
[TBL] [Abstract][Full Text] [Related]
3. Effects of AHR-5333, a new potential antiallergy compound, in in vivo models of immediate hypersensitivity.
Yanni JM; Foxwell MH
Int Arch Allergy Appl Immunol; 1988; 85(4):428-33. PubMed ID: 2895747
[TBL] [Abstract][Full Text] [Related]
4. Antiallergic effect of ZCR-2060: antihistaminic action.
Abe T; Omata T; Yoshida K; Matsumura T; Ikeda Y; Segawa Y; Matsuda K; Nagai H
Jpn J Pharmacol; 1994 Sep; 66(1):87-94. PubMed ID: 7861672
[TBL] [Abstract][Full Text] [Related]
5. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
Tasaka K; Kamei C; Akagi M; Mio M; Shirasaka T; Chokki M
Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
[TBL] [Abstract][Full Text] [Related]
6. Rocastine (AHR-11325), a rapid acting, nonsedating antihistamine.
Nolan JC; Stephens DJ; Proakis AG; Leonard CA; Johnson DN; Kilpatrick BF; Foxwell MH; Yanni JM
Agents Actions; 1989 Aug; 28(1-2):53-61. PubMed ID: 2571244
[TBL] [Abstract][Full Text] [Related]
7. Levocabastine: pharmacological profile of a highly effective inhibitor of allergic reactions.
Awouters F; Niemegeers CJ; Jansen T; Megens AA; Janssen PA
Agents Actions; 1992 Jan; 35(1-2):12-8. PubMed ID: 1354927
[TBL] [Abstract][Full Text] [Related]
8. CI-922--a novel, potent antiallergic compound--II. Activity in animal models of allergy.
Adolphson RL; Finkel MP; Robichaud LJ
Int J Immunopharmacol; 1987; 9(1):51-60. PubMed ID: 2438239
[TBL] [Abstract][Full Text] [Related]
9. Bronchodilator and antiallergic effects of thiazinamium chloride in guinea pigs, rats, cats and dogs.
Lewis AJ; Dervinis A; Rosenthale ME
Eur J Pharmacol; 1982 May; 80(2-3):171-84. PubMed ID: 6125398
[TBL] [Abstract][Full Text] [Related]
10. Effects of E-4716, a new antihistaminic with antiallergic properties, on chemical mediators induction of immunologic reactions.
Gutiérrez B; Dordal A; Fort M; Galicia J; Farré AJ
Methods Find Exp Clin Pharmacol; 1996; 18(6):397-406. PubMed ID: 8892269
[TBL] [Abstract][Full Text] [Related]
11. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent.
Yanni JM; Stephens DJ; Miller ST; Weimer LK; Graff G; Parnell D; Lang LS; Spellman JM; Brady MT; Gamache DA
J Ocul Pharmacol Ther; 1996; 12(4):389-400. PubMed ID: 8951675
[TBL] [Abstract][Full Text] [Related]
12. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.
Kreutner W; Hey JA; Anthes J; Barnett A; Young S; Tozzi S
Arzneimittelforschung; 2000 Apr; 50(4):345-52. PubMed ID: 10800633
[TBL] [Abstract][Full Text] [Related]
13. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. I. A lack of correlation between inhibition of cyclic nucleotide phosphodiesterases and antigen-induced release of histamine from rat mast cells.
Khandwala A; Van Inwegen R; Coutts S; Dally-Meade V; Jariwala N; Huang F; Musser J; Brown R; Loev B; Weinryb I
Int Arch Allergy Appl Immunol; 1984; 73(1):56-64. PubMed ID: 6198287
[TBL] [Abstract][Full Text] [Related]
14. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
15. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release.
Khandwala A; Coutts S; Pruss T; Jones H; Neiss E; Weinryb I
Biochem Pharmacol; 1987 Mar; 36(5):663-72. PubMed ID: 2435293
[TBL] [Abstract][Full Text] [Related]
16. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
[TBL] [Abstract][Full Text] [Related]
17. Antiallergic activity of picumast dihydrochloride in several animal species.
Roesch A; Schaumann W; Wilhelms OH
Arzneimittelforschung; 1989 Oct; 39(10A):1310-6. PubMed ID: 2576354
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo immunopharmacologic properties of a new antiallergic agent RHC 3414.
Khandwala A; Sonnino-Goldman P; Leibowitz M; Dally-Meade V; Donigi-Ruzza D
Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):103-22. PubMed ID: 6202252
[TBL] [Abstract][Full Text] [Related]
19. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
Fukuda T; Saito T; Tajima S; Shimohara K; Ito K
Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiallergic activity of 11-(aminoalkylidene)-6,11-dihydrodibenz[b,e]oxepin derivatives.
Ohshima E; Otaki S; Sato H; Kumazawa T; Obase H; Ishii A; Ishii H; Ohmori K; Hirayama N
J Med Chem; 1992 May; 35(11):2074-84. PubMed ID: 1350797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
